IOVS Genetics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2003;44:2966-2972.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.02-1164

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banin, E.
Right arrow Articles by Chevion, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banin, E.
Right arrow Articles by Chevion, M.

Injury Induced by Chemical Warfare Agents: Characterization and Treatment of Ocular Tissues Exposed to Nitrogen Mustard

Eyal Banin,1 Yair Morad,2 Eduard Berenshtein,3 Alexey Obolensky,1 Claudia Yahalom,1 Jacob Goldich,3 Fatih M. Adibelli,1 Gladys Zuniga,1 Maribel DeAnda,1 Jacob Pe’er,1 and Mordechai Chevion3

1From the Departments of Ophthalmology and 3Cellular Biochemistry and Human Genetics, Hebrew University-Hadassah Schools of Medicine and Dental Medicine, Jerusalem, Israel; and the 2Department of Ophthalmology, Assaf Harofeh Medical Center, Zrifin, Israel.

PURPOSE. Mustard agents are highly toxic and abundant warfare chemicals, primarily affecting ocular tissues, with no specific treatment antidote. The purpose of the present study was to examine the efficacy of novel metallocomplexes, known to inhibit the formation of highly reactive free radicals, to reduce ocular injury induced by nitrogen mustard (NM).

METHODS. One eye in each of 72 rabbits was exposed to 1% to 2% NM. Topical treatment with eye drops of a metallocomplex—either zinc- or gallium-desferrioxamine (Zn/DFO and Ga/DFO)—was compared with treatment with saline, zinc (chloride), or DFO alone. Examiners masked to the treatment groups assessed the extent of ocular injury and the response to treatment using clinical, histologic, and biochemical criteria.

RESULTS. Exposure to NM followed by administration of carrier alone (saline) caused severe and long-lasting injury to ocular anterior segment structures. Treatment with either Zn/DFO or Ga/DFO yielded marked protection (52%–64%), including faster healing of corneal epithelial erosions, less scarring and neovascularization, decreased inflammation in the anterior chamber, better maintenance of intraocular pressure, and less severe changes in the iris and lens. These were also associated with better preservation of systemic antioxidant status. Zinc or DFO alone afforded lower levels of protection. No toxic effects of these complexes were observed.

CONCLUSIONS. It is suggested that Zn/DFO or Ga/DFO, by virtue of their enhanced ability to infiltrate cells and inhibit transition metal-dependent formation of free radicals through the combined push–pull mechanism, be considered as a basis for treatment of mustard injuries.





This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Banin, A. Lozinski, K. M. Brady, E. Berenshtein, P. W. Butterfield, M. Moshe, M. Chevion, E. P. Greenberg, and E. Banin
The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent
PNAS, October 28, 2008; 105(43): 16761 - 16766.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Morad, E. Banin, E. Averbukh, E. Berenshtein, A. Obolensky, and M. Chevion
Treatment of Ocular Tissues Exposed to Nitrogen Mustard: Beneficial Effect of Zinc Desferrioxamine Combined with Steroids
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1640 - 1646.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology